Literature DB >> 19795986

Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.

K N Reitano1, S Kottilil, C M Gille, X Zhang, M Yan, M A O'Shea, G Roby, C W Hallahan, J Yang, R A Lempicki, J Arthos, A S Fauci.   

Abstract

HIV viremia is associated with a wide range of immune dysfunctions that contribute to the immunocompromised state. HIV viremia has been shown to have a broad effect on several immune cell types and/or their interactions that are vital for mounting an effective immune response. In this study, we investigated the integrity of plasmacytoid dendritic cell (pDC)-NK cell interactions among HIV viremic, aviremic, and seronegative individuals. We describe a critical defect in the ability of pDCs from HIV-infected individuals to secrete IFN-alpha and TNF and subsequently activate NK cells. We also describe an inherent defect on NK cells from HIV-infected individuals to respond to pDC-secreted cytokines. Furthermore, we were able to demonstrate a direct effect of HIV trimeric gp120 on NK cells in vitro similar to that described ex vivo. Finally, we were able to establish that the HIV gp120-mediated suppressive effect on NK cells was a result of its binding to the integrin alpha(4)beta(7) expressed on NK cells. These findings suggest a novel mechanism by which HIV is capable of suppressing an innate immune function in infected individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795986      PMCID: PMC2828160          DOI: 10.1089/aid.2008.0311

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  37 in total

Review 1.  On guard--activating NK cell receptors.

Authors:  L L Lanier
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

Review 2.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 3.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

4.  Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.

Authors:  Shyam Kottilil; Tae-Wook Chun; Susan Moir; Shuying Liu; Mary McLaughlin; Claire W Hallahan; Frank Maldarelli; Lawrence Corey; Anthony S Fauci
Journal:  J Infect Dis       Date:  2003-03-13       Impact factor: 5.226

Review 5.  Immunopathogenesis and immunotherapy in AIDS virus infections.

Authors:  Norman L Letvin; Bruce D Walker
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 6.  Toll-like receptor 9, CpG DNA and innate immunity.

Authors:  Ali A Ashkar; Kenneth L Rosenthal
Journal:  Curr Mol Med       Date:  2002-09       Impact factor: 2.222

7.  Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.

Authors:  Jeffrey A Martinson; Alejandro Roman-Gonzalez; Allan R Tenorio; Carlos J Montoya; Carolyne N Gichinga; Maria T Rugeles; Mark Tomai; Arthur M Krieg; Smita Ghanekar; Linda L Baum; Alan L Landay
Journal:  Cell Immunol       Date:  2008-03-10       Impact factor: 4.868

8.  A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.

Authors:  Ali M Harandi; Kristina Eriksson; Jan Holmgren
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.

Authors:  Domenico Mavilio; Janet Benjamin; Marybeth Daucher; Gabriella Lombardo; Shyam Kottilil; Marie A Planta; Emanuela Marcenaro; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-25       Impact factor: 11.205

Review 10.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

View more
  19 in total

Review 1.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 2.  Innate immunity in acute HIV-1 infection.

Authors:  Persephone Borrow
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

Review 3.  Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.

Authors:  Patricia Fitzgerald-Bocarsly; Evan S Jacobs
Journal:  J Leukoc Biol       Date:  2010-02-09       Impact factor: 4.962

Review 4.  Aging of the human innate immune system in HIV infection.

Authors:  Heidi J Zapata; Albert C Shaw
Journal:  Curr Opin Immunol       Date:  2014-07-02       Impact factor: 7.486

Review 5.  Dendritic cell dysregulation during HIV-1 infection.

Authors:  Elizabeth Miller; Nina Bhardwaj
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.

Authors:  Nancy P Y Chung; Katie Matthews; Per Johan Klasse; Rogier W Sanders; John P Moore
Journal:  J Immunol       Date:  2012-10-24       Impact factor: 5.422

7.  Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Jihed Chehimi; Emmanouil Papasavvas; Costin Tomescu; Bethsebah Gekonge; Shaheed Abdulhaqq; Andrea Raymond; Aidan Hancock; Kavita Vinekar; Craig Carty; Griffin Reynolds; Maxwell Pistilli; Karam Mounzer; Jay Kostman; Luis J Montaner
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

8.  Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.

Authors:  Nicole Prada; Guillemette Antoni; Frédéric Commo; Sylvie Rusakiewicz; Michaela Semeraro; Faroudy Boufassa; Olivier Lambotte; Laurence Meyer; Marie-Lise Gougeon; Laurence Zitvogel
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

Review 9.  A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection.

Authors:  Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

10.  Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network.

Authors:  Bi-Qing Li; Bing Niu; Lei Chen; Ze-Jun Wei; Tao Huang; Min Jiang; Jing Lu; Ming-Yue Zheng; Xiang-Yin Kong; Yu-Dong Cai
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.